Compare Immunovant Inc. Common Stock (IMVT) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Virgin Galactic Holdings, Inc. — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.25B), while Virgin Galactic Holdings, Inc. trades at $2.97 (market cap $445.69M). The key difference: Immunovant Inc. Common Stock is far larger — about 14× Virgin Galactic Holdings, Inc.'s market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Virgin Galactic Holdings, Inc. for 69 Days on average.
| IMVT | SPCE | |
|---|---|---|
Market Cap | $6.25B | $445.69M |
Volume | 1,755,411 | 5,128,850 |
Sector | Health | Industrials |
52-Week High | $44.96 | $7.52 |
52-Week Low | $17.03 | $2.17 |
Typical Hold Time | 0 Days | 69 Days |
Enterprise Value | $5.35B | $409.68M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Virgin Galactic (SPCE) trades at $3.01, down 1.95% on the day, reflecting persistent operational losses and a bearish technical outlook. The company continues to burn cash with negative gross and net profit margins, though recent earnings beats and strong ticket demand for future spaceflights offer a glimmer of hope. Cash flow trends show a gradual improvement, with a projected positive net cash flow of $25 million in 2026.
The outlook remains high-risk, high-reward. The path to profitability hinges on the successful commercial launch of Delta flights in 2027. While analyst sentiment is mixed and significant dilution and debt are concerns, the company's unique position in commercial spaceflight presents a speculative opportunity for investors with a long-term horizon and high risk tolerance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
